Ohcanbohtosat - Haiyong Han

Aiddostahte ozu
  1. 1
    RNA Interference to Knock Down Gene Expression

    RNA Interference to Knock Down Gene Expression Dahkki Haiyong Han

    Almmustuhtton 2018
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    RNA Interference to Knock Down Gene Expression

    RNA Interference to Knock Down Gene Expression Dahkki Haiyong, Han

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    SnapShot: Pancreatic Cancer

    SnapShot: Pancreatic Cancer Dahkki Haiyong Han, Daniel D. Von Hoff

    Almmustuhtton 2013
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    A DNA polymerase stop assay for G-quadruplex-interactive compounds

    A DNA polymerase stop assay for G-quadruplex-interactive compounds Dahkki Haiyong Han, Laurence H. Hurley, Miguel Salazar

    Almmustuhtton 1999
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Identification of an Agent Selectively Targeting DPC4 (Deleted in Pancreatic Cancer Locus 4)–Deficient Pancreatic Cancer Cells

    Identification of an Agent Selectively Targeting DPC4 (Deleted in Pancreatic Cancer Locus 4)–Deficient Pancreatic Cancer Cells Dahkki Hong Wang, Haiyong Han, Daniel D. Von Hoff

    Almmustuhtton 2006
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer

    Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer Dahkki Clifford J. Whatcott, Haiyong Han, Daniel D. Von Hoff

    Almmustuhtton 2015
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression

    Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression Dahkki Kazuhiro Yoshida, Shusuke Toden, Preethi Ravindranathan, Haiyong Han, Ajay Goel

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells

    Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells Dahkki Aditi Bapat, Rubén M. Muñoz, Daniel D. Von Hoff, Haiyong Han

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Tumor-Stromal Interactions in Pancreatic Cancer

    Tumor-Stromal Interactions in Pancreatic Cancer Dahkki Clifford J. Whatcott, Haiyong Han, Richard G. Posner, Daniel D. Von Hoff

    Almmustuhtton 2012
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumors

    Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumors Dahkki Ahmad Al‐Hader, Rami N. Al‐Rohil, Haiyong Han, Daniel D. Von Hoff

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Synergistic Effect between Erlotinib and MEK Inhibitors in KRAS Wild-Type Human Pancreatic Cancer Cells

    Synergistic Effect between Erlotinib and MEK Inhibitors in KRAS Wild-Type Human Pancreatic Cancer Cells Dahkki Caroline H. Diep, Rubén M. Muñoz, Ashish Choudhary, Daniel D. Von Hoff, Haiyong Han

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Targeting the Tumor Microenvironment in Cancer: Why Hyaluronidase Deserves a Second Look

    Targeting the Tumor Microenvironment in Cancer: Why Hyaluronidase Deserves a Second Look Dahkki Clifford J. Whatcott, Haiyong Han, Richard G. Posner, Galen Hostetter, Daniel D. Von Hoff

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer

    Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer Dahkki Clifford J. Whatcott, Serina Ng, Michael T. Barrett, Galen Hostetter, Daniel D. Von Hoff, Haiyong Han

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Increasing Stress to Induce Apoptosis in Pancreatic Cancer via the Unfolded Protein Response (UPR)

    Increasing Stress to Induce Apoptosis in Pancreatic Cancer via the Unfolded Protein Response (UPR) Dahkki Gehan Botrus, Max Miller, Pedro Luiz Serrano Usón, Geoffrey Kannan, Haiyong Han, Daniel D. Von Hoff

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapies

    Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapies Dahkki Jiayin Shen, Yingwen Hu, Karson S. Putt, Sunil Singhal, Haiyong Han, Daniel W. Visscher, Linda M. Murphy, Philip S. Low

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    The mitotic serine threonine kinase, <i>Aurora-2</i>, is a potential target for drug development in human pancreatic cancer

    The mitotic serine threonine kinase, <i>Aurora-2</i>, is a potential target for drug development in human pancreatic cancer Dahkki Sangeeta Rojanala, Haiyong Han, Rubén M. Muñoz, Walden Browne, Raymond B. Nagle, Daniel D. Von Hoff, David J. Bearss

    Almmustuhtton 2004
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer

    Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer Dahkki Phillip J. Gray, David J. Bearss, Haiyong Han, Raymond B. Nagle, Ming‐Sound Tsao, Nicholas Dean, Daniel D. Von Hoff

    Almmustuhtton 2004
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Down-Regulation of Yes Associated Protein 1 Expression Reduces Cell Proliferation and Clonogenicity of Pancreatic Cancer Cells

    Down-Regulation of Yes Associated Protein 1 Expression Reduces Cell Proliferation and Clonogenicity of Pancreatic Cancer Cells Dahkki Caroline H. Diep, Kelly Zucker, Galen Hostetter, Aprill Watanabe, Chengcheng Hu, Rubén M. Muñoz, Daniel D. Von Hoff, Haiyong Han

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    A phase II trial of the super-enhancer inhibitor Minnelide™ in advanced refractory adenosquamous carcinoma of the pancreas

    A phase II trial of the super-enhancer inhibitor Minnelide™ in advanced refractory adenosquamous carcinoma of the pancreas Dahkki Nebojša Skorupan, Mehwish Ahmad, Seth M. Steinberg, Jane B. Trepel, Derek Cridebring, Haiyong Han, Daniel D. Von Hoff, Christine Alewine

    Almmustuhtton 2022
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Validation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells

    Validation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells Dahkki Steven L. Warner, Bret J. Stephens, Stanley Nwokenkwo, Galen Hostetter, Anastasia Sugeng, Manuel Hidalgo, Jeffery M. Trent, Haiyong Han, Daniel D. Von Hoff

    Almmustuhtton 2009
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: